Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M

FEBS Letters

Volumn 459, Issue 3, 1999, Pages 453-457

  Pourtau, Jérôme ^a   Mirshahi, Farrokh ^a   Li, Hong ^a   Muraine, Marc ^a,b   Vincent, Loïc ^a   Tedgui, Alain ^c   Vannier, Jean Pierre ^a   Soria, Jeannette ^d   Vasse, Marc ^a   Soria, Claudine ^a,e  

^a UNIVERSITÉ DE ROUEN   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔTEL DIEU   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Angiogenesis; Cyclooxygenase 2; Macrophage; Monocyte; Oncostatin M

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONCOSTATIN M;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHEMOTAXIS; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CORNEA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NITROBENZENES; ONCOSTATIN M; PEPTIDES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RABBITS; RNA, MESSENGER; SULFONAMIDES;

EID: 0032858796     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01301-0     Document Type: Article

References (14)

1. Vasse M., Collet J.-P., Soria J., Mirshahi S.-S., Vannier J.-P., Soria C. Thromb. Res. 75:1994;349-352.
2. Modur V., Feldhaus M.J., Weyrich A.S., Jicha D.L., Prescott S.M., Zimmerman G.A., McIntyre T.M. J. Clin. Invest. 100:1997;158-168.
3. Vasse, M., Pourtau, J., Trochon, V., Muraine, M., Vannier, J.-P., Lu, H., Soria, J. and Soria, C. (1999) Arterioscler. Thromb. Vasc. Biol. (in press).
4. Smith W.L., Garavito R.M., DeWitt D.L. J. Biol. Chem. 271:1996;33157-33160.
5. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cell. 93:1998;705-716.
6. Majima M., Isono M., Ikeda Y., Hayashi I., Hatanaka K., Harada Y., Katsumata O., Yamashina S., Katori M., Yamamoto S. Jpn. J. Pharmacol. 75:1997;105-114.
7. Ristimaki A., Garfinkel S., Wessendorf J., Maciag T., Hla T. J. Biol. Chem. 269:1994;11769-11775.
8. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., Lawley T.J. J. Invest. Dermatol. 99:1992;683-690.
9. Jaffe E.A., Nachman R.L., Becker C.G., Minick R. J. Clin. Invest. 352:1997;2745-2756.
10. Bradford M. Anal. Biochem. 72:1976;248-250.
11. Bishop-Bailey D., Pepper J.R., Larkin S.W., Mitchell J.A. Arterioscler. Thromb. Vasc. Biol. 18:1998;1655-1661.
12. Kage K., Fujita N., Oh-hara T., Ogata E., Fujita T., Tsuruo T. Biochem. Biophys. Res. Commun. 254:1999;259-263.
13. Sutton A.B., Canfield A.E., Schor S.L., Grant M.E., Schor A.M. J. Cell. Sci. 99:1991;777-787.
14. Baker C.S.R., Hall R.J.C., Evans T.J., Pomerance A., Maclouf J., Creminon C., Yacoub M.H., Polak J.M. Arterioscler. Thromb. Vasc. Biol. 19:1999;646-655.